The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

team
When Your Team Becomes the Bottleneck
February 25, 2026

In a candid take on organizational blind spots, Mollie Gaby, Principal at CG Infinity, highlights a hard truth many leaders avoid: sometimes your biggest pain point isn’t your technology or your strategy — it’s your staff. A common red flag is resistance to change. When team members are unwilling to explore new tools, automate…

Read More
asset visibility
Diagnosing Your Capital Asset Health: Why Asset Visibility Is the New Financial Imperative in Healthcare
February 25, 2026

Hospitals and surgery centers own millions of dollars in equipment — but owning assets and having actionable visibility into them are two different things. Most systems maintain inventories, yet many struggle with outdated records, fragmented tracking, and limited insight into useful life or service contracts. With nearly half of U.S. hospitals reporting negative operating…

Read More
CFO
From Public Accounting to CFO: The Leadership Wake-Up Call
February 25, 2026

The CFO seat is being rewritten in real time. Today’s finance leaders are expected to drive growth, lead enterprise-wide systems transformations, and shape AI strategy—while still keeping the close, controls, and capital story airtight. Gartner reports that 59% of finance leaders are already using AI in the finance function, underscoring how rapidly the role is…

Read More
restorative practices
Building Safer Schools Through Restorative Practices
February 24, 2026

School Safety Today podcast, presented by Raptor Technologies. In this episode of Principals of Change, host Dr. Amy Grosso sits down with D’Jon Pitchford, Assistant Principal at Kelly Lane Middle School in Pflugerville ISD, to explore what school safety really means. Pitchford reframes safety as more than physical security—emphasizing trust, restorative practices, campus culture,…

Read More